Abstract
The various forms of adjuvant therapy in breast cancer including postoperative irradiation and chemotherapy or hormonal therapy decrease the mortality rate among the affected population. Adjuvant radiotherapy is a standard form of treatment after breast-conserving surgery and certain mastectomized patients. Periodically, some patients can suffer from long-term toxicity such as radiation pneumonitis or radiation fibrosis of the lung. In very rare situations after breast radiotherapy, bilateral lymphocytic alveolitis of the lung (BAL) can occur. BAL is an accepted allergic reaction of the lung and this form has different etiologic and pathologic factors apart from radiation pneumonitis and radiation fibrosis. BAL is a bilateral reaction of the lung but it occurs after unilateral thoracic apex irradiation resulting from radiotherapy in breast carcinoma patients [1]. In one study, patients with pneumonitis at the time of BAL had significantly higher (p<0.05) alveolar CD4 subset cells (24.8±10.2%) than asymptomatic patients (15.2±8.9%). Maximal reductions in total lung capacity (p<0.01) and residual volume (p<0.05) occurred 60 days after irradiation. The early lymphocytic alveolitis which can occur in breast cancer patients after unilateral irradiation is always bilateral and does not predict subsequent development of radiologic evidence of pneumonitis [1, 2]. This situation is different than radiation pneumonitis and fibrosis. True radiation pneumonitis and fibrosis resulting from radiotherapy in breast carcinoma patients is of different incidence. The incidence changes because of reasons such as usage of particular drugs and radiation therapy techniques, as well as other causes. Nonetheless, radiotherapy of the breast can cause long-term effects such as radiation pneumonitis and fibrosis on lung, or skin reactions such as dermatitis or fibrosis. The incidence of lung injury resulting from radiation in breast cancer patients varies between 4.5% and 63% [3]. Some radiation pneumonitis and fibrosis are silent. However, when imaging modalities are used, side effects can be seen. Because the irradiated lung volume is very small, most of these side effects do not change patient activities of daily living or lung capabilities.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Martin C, Romero S, Sanchez-Paya J, et al. Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation. Eur Respir J. 1999;13(4):727–32.
Bayle JY, Nesme P, Bejui-Thivolet F, et al. Migratory organizing pneumonitis “primed” by radiation therapy. Eur Respir J. 1995;8(2):322–6.
Varga Z, Cserhati A, Kelemen G, et al. Role of systemic in the development of lung sequelae after conformal radiotherapy in breast cancer. Int J Radiat Oncol Biol Phys. 2011;80(4):1109–16.
Tsoutsou PG, Blacemi Y, Gligoro J, et al. Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. Oncologist. 2010;15:1169–78.
Koc M, Polat P, Suma S, et al. Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiother Oncol. 2001;64:171–5.
Bese NS, Umay C, Yildirim S, et al. The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: results an experimental study. Breast. 2006;15:456–60.
Harris EER, Christensen VJ, Hwang WT, et al. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol. 2005;23(1):11–6.
Ahn PH, Vu HT, Lannin D, et al. Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol. 2005;23:17–23.
Valakh V, Trombetta MG, Werts ED, et al. Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy. Am J Clin Oncol. 2011;34:245–8.
Azria D, Belkacemi Y, Romieu G, et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 2010;11:258–65.
Munshi A, Gupta D. Concurrent versus sequential radiotherapy and tamoxifen in breast cancer—the CONSET trial is launched. Acta Oncol. 2011;50:154–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Akmansu, M. (2013). Interactions of Radiotherapy With Hormonotherapy. In: Haydaroglu, A., Ozyigit, G. (eds) Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5116-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5116-7_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5115-0
Online ISBN: 978-1-4614-5116-7
eBook Packages: MedicineMedicine (R0)